These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 30829728)

  • 61. Frequency of pain and correlation with clinical and histologic parameters in T1 squamous cell carcinoma of the tongue: a retrospective pilot study.
    Nikitakis NG; Sarlani E; Kolokythas A; Scheper MA; Kamperos G; Ord RA; Sklavounou-Andrikopoulou A
    J Oral Facial Pain Headache; 2014; 28(1):46-51. PubMed ID: 24482787
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Colorectal carcinoma grading by quantifying poorly differentiated cell clusters is more reproducible and provides more robust prognostic information than conventional grading.
    Barresi V; Reggiani Bonetti L; Branca G; Di Gregorio C; Ponz de Leon M; Tuccari G
    Virchows Arch; 2012 Dec; 461(6):621-8. PubMed ID: 23093109
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Prognostic factors and outcomes for salvage surgery in patients with recurrent squamous cell carcinoma of the tongue.
    Goto M; Hanai N; Ozawa T; Hirakawa H; Suzuki H; Hyodo I; Kodaira T; Ogawa T; Fujimoto Y; Terada A; Kato H; Hasegawa Y
    Asia Pac J Clin Oncol; 2016 Mar; 12(1):e141-8. PubMed ID: 23909955
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Overexpression of Hippo pathway effector TAZ in tongue squamous cell carcinoma: correlation with clinicopathological features and patients' prognosis.
    Wei Z; Wang Y; Li Z; Yuan C; Zhang W; Wang D; Ye J; Jiang H; Wu Y; Cheng J
    J Oral Pathol Med; 2013 Nov; 42(10):747-54. PubMed ID: 23551691
    [TBL] [Abstract][Full Text] [Related]  

  • 65. For early-stage oral tongue cancer, depth of invasion and worst pattern of invasion are the strongest pathological predictors for locoregional recurrence and mortality.
    Almangush A; Bello IO; Coletta RD; Mäkitie AA; Mäkinen LK; Kauppila JH; Pukkila M; Hagström J; Laranne J; Soini Y; Kosma VM; Koivunen P; Kelner N; Kowalski LP; Grénman R; Leivo I; Läärä E; Salo T
    Virchows Arch; 2015 Jul; 467(1):39-46. PubMed ID: 25838076
    [TBL] [Abstract][Full Text] [Related]  

  • 66. DNA base excision repair proteins APE-1 and XRCC-1 are overexpressed in oral tongue squamous cell carcinoma.
    Santana T; Sá MC; de Moura Santos E; Galvão HC; Coletta RD; Freitas RA
    J Oral Pathol Med; 2017 Aug; 46(7):496-503. PubMed ID: 27925687
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Machine learning application for prediction of locoregional recurrences in early oral tongue cancer: a Web-based prognostic tool.
    Alabi RO; Elmusrati M; Sawazaki-Calone I; Kowalski LP; Haglund C; Coletta RD; Mäkitie AA; Salo T; Leivo I; Almangush A
    Virchows Arch; 2019 Oct; 475(4):489-497. PubMed ID: 31422502
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Risk factors for late cervical lymph node metastases in patients with stage I or II carcinoma of the tongue.
    Kurokawa H; Yamashita Y; Takeda S; Zhang M; Fukuyama H; Takahashi T
    Head Neck; 2002 Aug; 24(8):731-6. PubMed ID: 12203797
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A Grading System Combining Tumor Budding and Nuclear Diameter Predicts Prognosis in Resected Lung Squamous Cell Carcinoma.
    Kadota K; Miyai Y; Katsuki N; Kushida Y; Matsunaga T; Okuda M; Yokomise H; Kanaji N; Bandoh S; Haba R
    Am J Surg Pathol; 2017 Jun; 41(6):750-760. PubMed ID: 28248819
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Histological grading of malignancy in squamous cell carcinoma of the oral tongue.
    Holm LE; Lundquist PG; Silfverswärd C; Sobin A
    Acta Otolaryngol; 1982; 94(1-2):185-92. PubMed ID: 7124386
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Histologic evaluation of host immune microenvironment and its prognostic significance in oral tongue squamous cell carcinoma: a comparative study on lymphocytic host response (LHR) and tumor infiltrating lymphocytes (TILs).
    Xu B; Salama AM; Valero C; Yuan A; Khimraj A; Saliba M; Zanoni DK; Ganly I; Ghossein R; Patel SG; Katabi N
    Pathol Res Pract; 2021 Dec; 228():153473. PubMed ID: 34059347
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Activin A immunoexpression as predictor of occult lymph node metastasis and overall survival in oral tongue squamous cell carcinoma.
    Kelner N; Rodrigues PC; Bufalino A; Fonseca FP; Santos-Silva AR; Miguel MC; Pinto CA; Leme AF; Graner E; Salo T; Kowalski LP; Coletta RD
    Head Neck; 2015 Apr; 37(4):479-86. PubMed ID: 24677273
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A novel prognostic model for tongue squamous cell carcinoma based on the characteristics of tumour and its microenvironment: iBD score.
    Yu P; Wang W; Zhuang Z; Xie N; Xu J; Wang C; Hou J; Han X; Liu X
    Histopathology; 2019 Apr; 74(5):766-779. PubMed ID: 30444275
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A 22 years survival and prognostic factors analysis in a homogeneous series of 64 patients with advanced cancer of the tongue and the floor of the mouth.
    López-Cedrún JL; Andrés de Llano J
    J Craniomaxillofac Surg; 2015 Apr; 43(3):376-81. PubMed ID: 25703504
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The chromophobe tumor grading system is the preferred grading scheme for chromophobe renal cell carcinoma.
    Finley DS; Shuch B; Said JW; Galliano G; Jeffries RA; Afifi AA; Castor B; Magyar C; Sadaat A; Kabbinavar FF; Belldegrun AS; Pantuck AJ
    J Urol; 2011 Dec; 186(6):2168-74. PubMed ID: 22014797
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Risk stratification of early stage oral tongue cancers based on HPV status and p16 immunoexpression.
    Ramshankar V; Soundara VT; Shyamsundar V; Ramani P; Krishnamurthy A
    Asian Pac J Cancer Prev; 2014; 15(19):8351-9. PubMed ID: 25339028
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Challenging the Requirement to Treat the Contralateral Neck in Cases With >4 mm Tumor Thickness in Patients Receiving Postoperative Radiation Therapy for Squamous Cell Carcinoma of the Oral Tongue or Floor of Mouth.
    O'steen L; Amdur RJ; Morris CG; Hitchcock KE; Mendenhall WM
    Am J Clin Oncol; 2019 Jan; 42(1):89-91. PubMed ID: 30234502
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Clinical Outcomes in pT4 Tongue Carcinoma are Worse than in pT3 Disease: How Extrinsic Muscle Invasion Should be Considered?
    Liao CT; Lee LY; Hsueh C; Lin CY; Fan KH; Wang HM; Hsieh CH; Ng SH; Lin CH; Tsao CK; Kang CJ; Fang TJ; Huang SF; Chang KP; Yang LY; Yen TC
    Ann Surg Oncol; 2017 Sep; 24(9):2570-2579. PubMed ID: 28577181
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Multivariate analysis for prognostic predictors in the cN0 squamous cell carcinoma of the tongue].
    Zhao H; Zeng ZY; Chen FJ; Xu GP; Wu GH; Guo ZM; Zhang Q
    Ai Zheng; 2003 Feb; 22(2):206-9. PubMed ID: 12600302
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Oral tongue squamous cell carcinoma survival as stratified by age and sex: A surveillance, epidemiology, and end results analysis.
    Mukdad L; Heineman TE; Alonso J; Badran KW; Kuan EC; St John MA
    Laryngoscope; 2019 Sep; 129(9):2076-2081. PubMed ID: 30575045
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.